Product Information

BUPROPION HCL XL 150 MG TABLET is a generic product labeled by TWi Pharmaceuticals, Inc., priced at $0.0779 per EA under NDC 24979010102. Its NADAC has been published 406 times since Sep 26, 2018.

FDA first approved this application on Nov 3, 2017.

BUPROPION HCL XL 150 MG TABLET

bupropion hydrochloride
$0.0779per EA

Strength

150 mg/1

NDC

24979010102

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

6/17/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210081

FDA Approved

11/3/2017

On Market Since

8/30/2018

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 406 times since Sep 26, 2018, and over the history we have for it it has declined 74.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0779 per EA
All-time high$0.3117 (Aug 14, 2019)
All-time low$0.0745 (Nov 20, 2024)
52-week high$0.1015
52-week low$0.0770
Median price$0.1202
Average price$0.1497
Largest weekly change-30.3% (Nov 20, 2024)
Weeks tracked406
Tracking sinceSep 26, 2018

Price History

1W

N/A

1M

N/A

3M

-1.4%

6M

-0.9%

1Y

-23.3%

3Y

-22.9%

5Y

-50.2%

All

-74.4%

Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by TWi Pharmaceuticals, Inc., is $0.0779 per EA (NDC 24979010102), effective Jul 1, 2026.

How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 74.4%. It has been tracked across 406 weekly CMS publications since Sep 26, 2018.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?

Since Sep 26, 2018, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0745 (Nov 20, 2024) to a high of $0.3117 (Aug 14, 2019), with a median of $0.1202 per EA.

Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?

14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL XL 150 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPROPION HCL XL 150 MG TABLET?

BUPROPION HCL XL 150 MG TABLET (NDC 24979010102) is labeled by TWi Pharmaceuticals, Inc., and CMS classifies it as a generic product.